Doç. Dr. FUNDA TANRIKULU | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 10

1. Orak hücreli anemi Hastalarında Trombosit, Ortalama Trombosit Hacmi ve Beyaz Kan Hücresi Değerlerinin Klinik Komplikasyonlar ile İlişkisinin Araştırılması

Kılınç S., Tanrikulu F. P., Ölçüoğlu R., Çakmak E., KOZANOGLU I.

Osmangazi Tıp Dergisi , cilt.47, sa.2, ss.293-302, 2025 (TRDizin)

2. Functions of the endothelium and its role in hematopoietic cell transplantation.

Kozanoglu I., Pepedil-Tanrikulu F.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.61, sa.1, ss.103368, 2022 (SCI-Expanded, Scopus)

3. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.

Tombak A., Pepedil Tanrıkulu F., Durusoy S. S., Dinçyürek H. D., Kaya E., Ümit E. G., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.38, sa.4, ss.273-285, 2021 (SCI-Expanded, Scopus, TRDizin)

4. Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia.

Bostan H., Toptas T., Tanrikulu F., Kut K., Arikan F., Yilmaz F., et al.

Clinical lymphoma, myeloma & leukemia , cilt.20, sa.12, ss.836-842, 2020 (SCI-Expanded, Scopus)

5. The Impact of the Ferric Carboxymaltose on Hemoglobin and Ferritin Levels.

Korur A., Gereklioğlu Ç., Asma S., Aytan P., Tanrikulu F., Solmaz S., et al.

Clinical laboratory , cilt.66, sa.8, 2020 (SCI-Expanded, Scopus)

6. Significance of Lymphocyte Count, Monocyte Count, and Lymphocyte-To-Monocyte Ratio in Predicting Molecular Response in Patients with Chronic Myeloid Leukemia: a Single-Centre Experience.

Pepedil-Tanrikulu F., Buyukkurt N., Korur A., Sariturk C., Aytan P., Boga C., et al.

Clinical laboratory , cilt.66, sa.3, 2020 (SCI-Expanded, Scopus)

7. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience.

Çekdemir D., Güvenç S., Özdemirkıran F., Eser A., Toptaş T., Özkocaman V., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded, Scopus, TRDizin)

8. A Novel Simplified Combination of Monoclonal Antibodies for Flow Cytometric Analysis of Bronchoalveolar Lavage Samples.

Pepedil-Tanrikulu F., Sen N., Buyukkurt N., Sariturk C., Kozanoglu I.

Clinical laboratory , cilt.65, sa.9, 2019 (SCI-Expanded, Scopus)

9. Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.

Eser A., Toptas T., Kara O., Sezgin A., Noyan-Atalay F., Yilmaz G., et al.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , cilt.27, sa.1, ss.47-52, 2016 (SCI-Expanded, Scopus)

10. Aplastic anemia associated with oral terbinafine: a case report and review of the literature.

Kantarcıoğlu B., Türköz H. K., Yılmaz G., Pepedil Tanrıkulu F., Kaygusuz Atagündüz I., Adıgüzel C., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.31, sa.4, ss.411-6, 2014 (SCI-Expanded, Scopus, TRDizin)

Metrikler

Yayın

10

Yayın (WoS)

9

Yayın (Scopus)

9

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

1